source
- Pfizer drops two obesity programs, including Metsera-derived GLP-1 candidate, in pipeline cleanoutPfizer announced it is removing two clinical‑stage obesity programs as part of its quarterly pipeline cleanout. The first program, MET-224o, is an oral ultra‑long‑acting GLP‑1 receptor agonist tha…
- KKR to acquire medtech maker Integer in $5.7 billion dealKKR announced an agreement to take Integer private for approximately $5.7 billion, offering $127 per share in cash to Integer stockholders. Integer, based in Plano, Texas, saw its shares rise abou…